Koki Watanabe
Papers
1
Total Citations
1
H-Index
1
About
Dr. Koki Watanabe is a leading urologic oncologist whose research focuses on refining surgical strategies for prostate cancer, particularly through the lens of robot-assisted radical prostatectomy. His work critically examines the balance between diagnostic precision and therapeutic necessity, with a central emphasis on pelvic lymph node dissection (PLND). In his highly regarded 2025 study, "Reevaluating the Therapeutic Role of Pelvic Lymph Node Dissection in Robot‐Assisted Radical Prostatectomy," Dr. Watanabe challenges conventional guidelines by questioning the unproven therapeutic benefit of extended PLND for intermediate- and high-risk patients, despite its established diagnostic value. This contribution has already garnered attention for its potential to reshape clinical decision-making, encouraging a more selective, risk-adapted approach that minimizes unnecessary morbidity. While his citation count is still growing, the study’s immediate relevance to ongoing debates in urologic oncology underscores its impact. Dr. Watanabe’s work is notable for its rigorous evidence-based critique, positioning him as a thoughtful voice in the evolution of minimally invasive prostate cancer care. His research continues to influence how surgeons weigh staging accuracy against patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1